PURPLE BIOTECH LTD. Operating Expense
PURPLE BIOTECH LTD. (PPBT) reported Operating Expense of $27.46 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-19.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2026-03-19
| Period end | Operating Expense 12 month | Operating Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $27.46M 20-F · filed 2026-03-19 | |
| 2024-12-31 | $11.01M 20-F · filed 2026-03-19 | |
| 2023-12-31 | $22.27M 20-F · filed 2026-03-19 | |
| 2022-12-31 | $22.60M 20-F · filed 2025-03-10 | |
| 2021-12-31 | $17.93M 20-F · filed 2023-03-03 | |
| 2020-12-31 | $13.24M 20-F · filed 2023-03-03 | $13.61M 20-F · filed 2021-03-16 |
| 2019-12-31 | $6.67M 20-F · filed 2022-03-09 | $8.16M 20-F · filed 2020-03-23 |
| 2018-12-31 | $8.83M 20-F · filed 2021-03-16 | |
| 2017-12-31 | $12.07M 20-F · filed 2020-03-23 | |
| 2016-12-31 | $7.18M 20-F · filed 2019-03-26 |